Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 8, 2014, Pages 3080-3085

  Ito, Koyu ^a   Morimoto, Junko ^a   Kihara, Akio ^a   Matsui, Yutaka ^a   Kurotaki, Daisuke ^a   Kanayama, Masashi ^a   Simmons, Szandor ^b   Ishii, Masaru ^b   Sheppard, Dean ^c   Takaoka, Akinori ^a   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Lymphocyte trafficking; Matricellular proteins

Indexed keywords

55A 2C; ALPHA9 INTEGRIN; BLOCKING ANTIBODY; FINGOLIMOD; FREUND ADJUVANT; GLYCOPROTEIN; SPHINGOSINE 1 PHOSPHATE; TENASCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DEGRADATION; DRUG EFFECT; EMBRYO; ENDOTHELIUM CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECRETION (PROCESS); SYNTHESIS;

AUTOIMMUNE DISEASE; LYMPHOCYTE TRAFFICKING; MATRICELLULAR PROTEINS;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FREUND'S ADJUVANT; HISTOLOGICAL TECHNIQUES; IMMUNOLOGIC SURVEILLANCE; INTEGRIN ALPHA CHAINS; LYMPH NODES; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; SPHINGOSINE; STATISTICS, NONPARAMETRIC; TENASCIN;

EID: 84896822850     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311022111     Document Type: Article

References (37)

1. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K (2004) Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25(7):387-395. (Pubitemid 38780956)
2. von Andrian UH, Mempel TR (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3(11):867-878.
3. Berlin-Rufenach C, et al. (1999) Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med 189(9):1467-1478. (Pubitemid 29227533)
4. Lo CG, Lu TT, Cyster JG (2003) Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 197(3):353-361. (Pubitemid 36184242)
5. Schwab SR, et al. (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309(5741):1735-1739. (Pubitemid 41285945)
6. Pappu R, et al. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316(5822):295-298. (Pubitemid 46633109)
7. Pham TH, et al. (2010) Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 207(1):17-27.
8. Mendoza A, et al. (2012) The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep 2(5):1104-1110.
9. Hirakawa S, et al. (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109(3):1010-1017. (Pubitemid 46220646)
10. Mishima K, et al. (2007) Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol Biol Cell 18(4):1421-1429. (Pubitemid 46626636)
11. Hos D, et al. (2008) Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 49(5):1836-1842.
12. Okazaki T, et al. (2009) alpha5beta1 integrin blockade inhibits lymphangiogenesis in airway inflammation. Am J Pathol 174(6):2378-2387.
13. Garmy-Susini B, Varner JA (2008) Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol 6(3-4):155-163.
14. Huang XZ, et al. (2000) Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 20(14):5208-5215. (Pubitemid 30431573)
15. Bazigou E, et al. (2009) Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17(2):175-186.
16. Vlahakis NE, Young BA, Atakilit A, Sheppard D (2005) The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 280(6):4544-4552. (Pubitemid 40288622)
17. Grigorova IL, et al. (2009) Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat Immunol 10(1):58-65.
18. Webster B, et al. (2006) Regulation of lymph node vascular growth by dendritic cells. J Exp Med 203(8):1903-1913. (Pubitemid 44188465)
19. Angeli V, et al. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24(2):203-215. (Pubitemid 43214589)
20. Saito S, et al. (1999) The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem 274(43):30756-30763.
21. Midwood K, et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15(7):774-780.
22. Mandala S, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296(5566):346-349. (Pubitemid 34303689)
23. Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG (2008) S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28(1):122-133.
24. Brinkmann V, Cyster JG, Hla T (2004) FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4(7):1019-1025. (Pubitemid 38868590)
25. Kanayama M, et al. (2009) Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol 182(12):8015-8025.
26. Imanaka-Yoshida K (2012) Tenascin-C in cardiovascular tissue remodeling: From development to inflammation and repair. Circ J 76(11):2513-2520.
27. Matloubian M, et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427(6972):355-360. (Pubitemid 38133663)
28. Yang L, Yatomi Y, Miura Y, Satoh K, Ozaki Y (1999) Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol 107(2):282-293. (Pubitemid 29530212)
29. Laudanna C, Kim JY, Constantin G, Butcher E (2002) Rapid leukocyte integrin activation by chemokines. Immunol Rev 186(1):37-46.
30. Pepinsky RB, et al. (2002) Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1. Biochemistry 41(22):7125-7141. (Pubitemid 34575686)
31. Griffin GK, et al. (2012) IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 188(12):6287-6299.
32. Gray EE, Cyster JG (2012) Lymph node macrophages. J Innate Immun 4(5-6):424-436.
33. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205(7):1535-1541. (Pubitemid 351962016)
34. Yang Y, et al. (2009) T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 206(7):1549-1564.
35. Kihara A, Igarashi Y (2008) Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim Biophys Acta 1781(9):496-502.
36. Fukuhara S, et al. (2012) The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest 122(4): 1416-1426.
37. Bettelli E, et al. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197(9): 1073-1081. (Pubitemid 36570063)